Raymond James Adjusts Price Target for Dyne Therapeutics (NASDAQ: DYN) to $37
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameDyne Therapeutics, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









